Birmingham, AL, United States of America

J Anthony Thompson

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: J Anthony Thompson: Innovator in Retroviral Vector Technology

Introduction

J Anthony Thompson is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of biotechnology, particularly in the development of retroviral vectors. His innovative work has implications for gene transfer and therapeutic applications.

Latest Patents

Thompson holds a patent for a retroviral vector that includes a multiple cloning site with no greater than about 70 base pairs. This vector features at least four different enzyme restriction sites, with at least two sites having an average frequency of appearance in eukaryotic genes of less than one in 10,000 base pairs. The design allows for efficient gene and promoter transfers between the retroviral vector and a shuttle cloning vector, streamlining the process without the need for reconstructing the entire retroviral vector. Additionally, his invention includes a retroviral vector with a mutated 3' LTR promoter sequence, rendering it nonfunctional.

Career Highlights

Throughout his career, Thompson has worked with notable organizations, including Genetic Therapy, Inc. and the United States of America as represented by the Secretary Department. His work has been pivotal in advancing the understanding and application of retroviral vectors in genetic research.

Collaborations

Thompson has collaborated with esteemed colleagues such as Martin Eglitis and W French Anderson, contributing to the collective knowledge and advancements in the field of biotechnology.

Conclusion

J Anthony Thompson's innovative work in retroviral vector technology has paved the way for advancements in gene therapy and genetic research. His contributions continue to influence the field and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…